MedTrace Logo

Effectiveness of the Updated Version of the School-based Program Diario Della Salute (DDS-2)

NCT02683811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3600

Last updated 2016-07-28

No results posted yet for this study

Summary

This study evaluates the short- and long-term effects on psychological wellbeing and health-related behaviours of the updated version of a universal school-based program called Diario della Salute (DDS-2) in Italian students aged 11-13 years.

Conditions

  • Adolescent Behavior
  • Health Behavior
  • Mental Health Wellness 1

Interventions

BEHAVIORAL

Diario della Salute (DDS-2)

The updated version of Diario della Salute program (DDS-2) includes: 1) teachers' manual, 2) a booklet for teens telling the story of four same-age students (e.g. experimenting with risky behaviours, conflicting feelings and thoughts, need for independence and control, etc.), 3) a booklet for parents telling the experience of a mum and a dad with teenage children (e.g. problems in the relationship with teenage children, family conflicts, parental control and supervision, family communication, etc.).

Sponsors & Collaborators

  • Eclectica Sas di Beccaria Franca, Ermacora Antonella e C.

    collaborator INDUSTRY

  • University of Turin, Italy

    collaborator OTHER

  • University of Eastern Piedmont

    collaborator OTHER

  • Azienda Sanitaria Locale CN2 Alba-Bra

    lead OTHER

Principal Investigators

  • Laura Marinaro · ASL CN2

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-02-29
Completion
2016-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02683811 on ClinicalTrials.gov